233 related articles for article (PubMed ID: 37453060)
21. Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).
Martin FT; Dwyer RM; Kelly J; Khan S; Murphy JM; Curran C; Miller N; Hennessy E; Dockery P; Barry FP; O'Brien T; Kerin MJ
Breast Cancer Res Treat; 2010 Nov; 124(2):317-26. PubMed ID: 20087650
[TBL] [Abstract][Full Text] [Related]
22. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
[TBL] [Abstract][Full Text] [Related]
23. Shp2 activation in bone marrow microenvironment mediates the drug resistance of B-cell acute lymphoblastic leukemia through enhancing the role of VCAM-1/VLA-4.
Yu K; Yin Y; Ma D; Lu T; Wei D; Xiong J; Zhou Z; Zhang T; Zhang S; Fang Q; Wang J
Int Immunopharmacol; 2020 Mar; 80():106008. PubMed ID: 31978797
[TBL] [Abstract][Full Text] [Related]
24. Interactions of human MSC with head and neck squamous cell carcinoma cell line PCI-13 reduce markers of epithelia-mesenchymal transition.
Böhrnsen F; Fricke M; Sander C; Leha A; Schliephake H; Kramer FJ
Clin Oral Investig; 2015 Jun; 19(5):1121-8. PubMed ID: 25346374
[TBL] [Abstract][Full Text] [Related]
25. Phenotypic and Functional Alterations of Hematopoietic Stem and Progenitor Cells in an In Vitro Leukemia-Induced Microenvironment.
Vernot JP; Bonilla X; Rodriguez-Pardo V; Vanegas NP
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216566
[TBL] [Abstract][Full Text] [Related]
26. Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling.
Zhang B; Li M; McDonald T; Holyoake TL; Moon RT; Campana D; Shultz L; Bhatia R
Blood; 2013 Mar; 121(10):1824-38. PubMed ID: 23299311
[TBL] [Abstract][Full Text] [Related]
27. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
28. Mesenchymal Stem Cells With Cancer-Associated Fibroblast-Like Phenotype Stimulate SDF-1/CXCR4 Axis to Enhance the Growth and Invasion of B-Cell Acute Lymphoblastic Leukemia Cells Through Cell-to-Cell Communication.
Pan C; Fang Q; Liu P; Ma D; Cao S; Zhang L; Chen Q; Hu T; Wang J
Front Cell Dev Biol; 2021; 9():708513. PubMed ID: 34733839
[No Abstract] [Full Text] [Related]
29. Cell adhesion-mediated mitochondria transfer contributes to mesenchymal stem cell-induced chemoresistance on T cell acute lymphoblastic leukemia cells.
Wang J; Liu X; Qiu Y; Shi Y; Cai J; Wang B; Wei X; Ke Q; Sui X; Wang Y; Huang Y; Li H; Wang T; Lin R; Liu Q; Xiang AP
J Hematol Oncol; 2018 Jan; 11(1):11. PubMed ID: 29357914
[TBL] [Abstract][Full Text] [Related]
30. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
31. Mesenchymal stem cells promote leukaemic cells aberrant phenotype from B-cell acute lymphoblastic leukaemia.
Rodríguez-Pardo VM; Aristizabal JA; Jaimes D; Quijano SM; de los Reyes I; Herrera MV; Solano J; Vernot JP
Hematol Oncol Stem Cell Ther; 2013; 6(3-4):89-100. PubMed ID: 24161606
[TBL] [Abstract][Full Text] [Related]
32. Reversal of epithelial-mesenchymal transition and inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy.
Cui Y; Zhao M; Yang Y; Xu R; Tong L; Liang J; Zhang X; Sun Y; Fan Y
Acta Biomater; 2022 Oct; 152():380-392. PubMed ID: 36028199
[TBL] [Abstract][Full Text] [Related]
33. BCR-ABL1-driven exosome-miR130b-3p-mediated gap-junction Cx43 MSC intercellular communications imply therapies of leukemic subclonal evolution.
Chai C; Sui K; Tang J; Yu H; Yang C; Zhang H; Li SC; Zhong JF; Wang Z; Zhang X
Theranostics; 2023; 13(12):3943-3963. PubMed ID: 37554265
[No Abstract] [Full Text] [Related]
34. An ARC-Regulated IL1β/Cox-2/PGE2/β-Catenin/ARC Circuit Controls Leukemia-Microenvironment Interactions and Confers Drug Resistance in AML.
Carter BZ; Mak PY; Wang X; Tao W; Ruvolo V; Mak D; Mu H; Burks JK; Andreeff M
Cancer Res; 2019 Mar; 79(6):1165-1177. PubMed ID: 30674535
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal stromal cells ameliorate oxidative stress-induced islet endothelium apoptosis and functional impairment via Wnt4-β-catenin signaling.
Wang L; Qing L; Liu H; Liu N; Qiao J; Cui C; He T; Zhao R; Liu F; Yan F; Wang C; Liang K; Guo X; Shen YH; Hou X; Chen L
Stem Cell Res Ther; 2017 Aug; 8(1):188. PubMed ID: 28807051
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow mesenchymal stromal cells affect the cell cycle arrest effect of genotoxic agents on acute lymphocytic leukemia cells via p21 down-regulation.
Zhang Y; Hu K; Hu Y; Liu L; Wang B; Huang H
Ann Hematol; 2014 Sep; 93(9):1499-508. PubMed ID: 24705889
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stromal cells induce epithelial-to-mesenchymal transition in human colorectal cancer cells through the expression of surface-bound TGF-β.
Mele V; Muraro MG; Calabrese D; Pfaff D; Amatruda N; Amicarella F; Kvinlaug B; Bocelli-Tyndall C; Martin I; Resink TJ; Heberer M; Oertli D; Terracciano L; Spagnoli GC; Iezzi G
Int J Cancer; 2014 Jun; 134(11):2583-94. PubMed ID: 24214914
[TBL] [Abstract][Full Text] [Related]
39. [Effects of acute lymphoblastic leukemia children bone marrow mesenchymal stem cells on drug resistance of K562/A02 cell line].
Wang ZX; Yang ZM; Zou YW; Li MM; Chen FX; Zhong GY; Guan JM; Wei FG; Wu SZ; He ZT; Wu ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):19-23. PubMed ID: 21362214
[TBL] [Abstract][Full Text] [Related]
40. [Mechanism of miR-155 Promoting Drug Resistance in Childhood Acute Lymphoblastic Leukemia by Regulating Wnt/β-Catenin Signaling Pathway].
Huang HM; Wei YJ; Wang D; Wen XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):418-424. PubMed ID: 35395973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
